If you want to add some blue chip ASX 200 dividend shares to your income portfolio, then read on.
That's because the two listed below have recently been named as buys and tipped to offer good dividend yields by analysts. Here's what they are recommending:
Image source: Getty Images
Sonic Healthcare Ltd (ASX: SHL)
The first ASX 200 dividend share that gets the thumbs up from analysts is healthcare company Sonic Healthcare.
Bell Potter is feeling bullish about the company. This is due to its belief that Sonic Healthcare's post-COVID turnaround and a return to sustainable growth are finally coming. It said:
SHL should return to growth, with c.7.9% / c.9.1% / c.9.7% revenue, EBITDA and Normalised NPAT growth. We expect EBITDA margins to begin to recover in FY25 and deliver c.110bp improvement through to FY27. Growth is being driven by right sizing the business, the impact of acquisitions in FY24 and normalising organic operations post COVID. Our estimates are broadly in line with consensus.
As for income, the broker is forecasting dividends per share of 107 cents in FY 2025 and then 109 cents in FY 2026. Based on its current share price of $26.27, this represents dividend yields of 4.1% and 4.15%, respectively.
Bell Potter has a buy rating and $33.70 price target on its shares.
Treasury Wine Estates Ltd (ASX: TWE)
Another ASX 200 dividend share that has been rated as a buy is wine giant Treasury Wine.
While trading conditions are tough, Morgans believes that its shares are just too cheap to ignore right now. It recently said:
A deceleration of US Premium wine sales (particularly 19 Crimes) below US$15 per bottle, has seen TWE revise its FY25 EBITS guidance. The downgrade was minor at 1.3% and better than feared. TWE's Luxury portfolios appear to be performing well. However, focus is now on what impact a change in distributor in TWE's key US market, declining Premium US wine sales and the tariffs will have on FY26. We have revised our forecasts. While not without risk given industry and macro headwinds, TWE's trading multiples look far too cheap (FY25 PE of only 14.2x) and we maintain a BUY rating.
In respect to dividends, the broker is forecasting partially franked payouts of 39.5 cents per share in FY 2025 and then 45 cents per share in FY 2026. Based on its current share price of $8.14, this would mean dividend yields of 4.85% and 5.5%, respectively.
Morgans has a buy rating and $11.06 price target on its shares.
